GO:1903799 negative regulation of miRNA processing: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903799 describes any process that stops, prevents or reduces the frequency, rate or extent of microRNA processing, thereby limiting production of mature miRNAs.
• Negative regulation of miRNA processing operates at multiple levels, including transcriptional repression of miRNA host genes, inhibition of Drosha/DGCR8 and Dicer/TRBP activities, and sequestration or degradation of primary and precursor miRNA transcripts.
• Dysregulation of this process contributes to acute leukemia, osteosarcoma, heart disease, and neuropsychiatric disorders through altered miRNA-mediated gene silencing.
• Key proteins controlling this negative regulation include Drosha, DGCR8, Dicer, TRBP, AGO2, LIN28, and multiple RNA-binding proteins that block pri-miRNA or pre-miRNA maturation.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of negative regulators of miRNA processing in disease-relevant cell types.
• Benchmarking studies highlight that accurate classification of miRNA-mRNA interactions depends on well-controlled negative data, underscoring the need for rigorous experimental design in this field.
Description
MicroRNAs (miRNAs) are small non-coding RNAs that guide post-transcriptional gene silencing by base-pairing with target mRNAs. The production of mature miRNAs requires sequential cleavage of primary miRNA transcripts (pri-miRNAs) by the Drosha/DGCR8 microprocessor complex in the nucleus and by Dicer in the cytoplasm. Negative regulation of miRNA processing, annotated as GO:1903799, encompasses any cellular process that reduces the frequency, rate or extent of these maturation steps, thereby lowering the abundance of functional miRNAs. This regulatory layer is critical because it provides a rapid and reversible mechanism to adjust miRNA output without altering the genomic sequence of miRNA genes. Research over the past two decades has revealed that negative regulation of miRNA processing is not a single pathway but a collection of mechanisms, including transcriptional repression of miRNA host genes, post-translational modification of microprocessor components, and direct binding of proteins or RNAs to pri-miRNAs and pre-miRNAs. For example, epigenetic silencing of miRNA genes in acute leukemia reduces mature miRNA levels and contributes to leukemogenesis. In osteosarcoma, altered miRNA processing is associated with tumor progression and poor prognosis. In the heart, dysregulated miRNA maturation contributes to cardiac hypertrophy and heart failure. Understanding GO:1903799 is therefore essential for researchers who study gene regulatory networks, because changes in miRNA processing can amplify or dampen entire gene expression programs. This article integrates the QuickGO definition with published literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental methods used to study negative regulation of miRNA processing.
negative regulation of miRNA processing At A Glance
| GO ID | GO:1903799 |
|---|---|
| GO term | negative regulation of miRNA processing |
| Ontology | biological_process |
| Synonym | down regulation of miRNA processing; inhibition of miRNA processing; negative regulation of miRNA maturation; downregulation of microRNA biogenesis |
| Major function | Reduces the production of mature microRNAs by inhibiting or preventing pri-miRNA and pre-miRNA maturation steps |
| Biological context | Operates in the nucleus and cytoplasm during miRNA biogenesis and gene silencing |
| Key regulators | Drosha, DGCR8, Dicer, TRBP, AGO2, LIN28, and RNA-binding proteins that block miRNA maturation |
| Disease relevance | Implicated in acute leukemia, osteosarcoma, heart disease, and neuropsychiatric disorders |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, small RNA-seq, and miRNA target reporter assays |
What Is GO:1903799?
GO:1903799, negative regulation of miRNA processing, is defined by QuickGO as any process that stops, prevents or reduces the frequency, rate or extent of microRNA processing. In practical terms, it includes all molecular events that decrease the conversion of primary miRNA transcripts into mature, functional miRNAs, whether by inhibiting the Drosha/DGCR8 microprocessor complex, blocking Dicer-mediated cleavage, promoting degradation of pri-miRNAs or pre-miRNAs, or repressing transcription of miRNA host genes.
Why Is negative regulation of miRNA processing Important in Cell Biology?
Negative regulation of miRNA processing is important because it determines the abundance of mature miRNAs, which in turn control the expression of hundreds of target mRNAs. By modulating this step, cells can rapidly reprogram gene expression networks in response to developmental, metabolic, or stress signals. Dysregulation of this process is linked to cancer, cardiovascular disease, and neurological disorders, making it a compelling area for both basic research and therapeutic target discovery.
• Controls the output of miRNA-mediated gene silencing, affecting broad gene expression programs.
• Provides a reversible mechanism to fine-tune miRNA levels without genomic alterations.
• Dysregulation contributes to acute leukemia through epigenetic silencing of miRNA genes.
• Altered miRNA processing is associated with osteosarcoma progression and metastasis.
• Impaired negative regulation of miRNA processing is linked to cardiac hypertrophy and heart failure.
• miRNA processing changes in the hypothalamus influence social and anxiety-related behaviors.
• Serves as a node for crosstalk between transcription factors, RNA-binding proteins, and epigenetic modifiers.
• Offers potential therapeutic targets for restoring normal miRNA profiles in disease.
• Requires rigorous negative data generation for accurate miRNA-mRNA interaction classification.
• Enables researchers to dissect causal roles of specific regulators using CRISPR-based models.
What Happens During negative regulation of miRNA processing?
Transcriptional repression of miRNA host genes
In simple terms: The cell can reduce miRNA production by turning down the gene that makes the primary miRNA transcript.
Many miRNA genes are transcribed by RNA polymerase II as part of longer host gene transcripts or as independent units. Negative regulation of miRNA processing can begin at the transcriptional level, where promoter methylation, histone deacetylation, or repressive transcription factors reduce the abundance of pri-miRNAs available for processing. In acute leukemia, epigenetic silencing of miRNA genes through DNA methylation and histone modifications leads to decreased mature miRNA levels, demonstrating that transcriptional repression is a key mechanism of negative regulation. This layer of control ensures that miRNA production can be shut down in response to oncogenic or developmental signals.
Inhibition of the Drosha/DGCR8 microprocessor complex
In simple terms: Proteins can block the molecular scissors that make the first cut in miRNA maturation.
The Drosha/DGCR8 microprocessor complex catalyzes the initial cleavage of pri-miRNAs into pre-miRNAs in the nucleus. Negative regulation of miRNA processing can occur through direct inhibition of Drosha or DGCR8 activity, post-translational modifications that reduce their catalytic efficiency, or sequestration of the complex away from pri-miRNA substrates. RNA-binding proteins can bind to pri-miRNA hairpins and prevent Drosha recruitment, thereby reducing pre-miRNA production. This step is a major checkpoint because it determines whether a pri-miRNA enters the maturation pathway.
Blockade of Dicer-mediated pre-miRNA cleavage
In simple terms: The second cutting step in the cytoplasm can also be stopped, preventing mature miRNA from forming.
After export to the cytoplasm, pre-miRNAs are cleaved by Dicer, in complex with TRBP, to generate miRNA duplexes. Negative regulation of miRNA processing can be achieved by inhibiting Dicer activity, reducing Dicer expression, or preventing the loading of pre-miRNAs onto Dicer. For example, certain RNA-binding proteins and viral factors can bind to pre-miRNAs or Dicer and block cleavage, leading to accumulation of pre-miRNAs and reduced mature miRNA levels. This cytoplasmic checkpoint provides an additional layer of control over miRNA output.
Degradation and sequestration of pri-miRNAs and pre-miRNAs
In simple terms: The cell can destroy or hide miRNA precursors before they become mature miRNAs.
Negative regulation of miRNA processing also includes pathways that degrade pri-miRNAs or pre-miRNAs through exonucleases or exosome-mediated decay. Sequestration of miRNA precursors by RNA-binding proteins or long non-coding RNAs can prevent access to Drosha or Dicer, effectively reducing mature miRNA production. In some cases, miRNA precursors are targeted for degradation in response to cellular stress or developmental cues, providing a rapid way to lower miRNA levels. These mechanisms ensure that miRNA processing can be attenuated without affecting the transcription of miRNA genes.
Regulation of Argonaute loading and miRNA stability
In simple terms: Even after processing, miRNAs can be prevented from working by blocking their loading into effector complexes.
Mature miRNAs must be loaded into Argonaute proteins to form the RNA-induced silencing complex (RISC). Negative regulation of miRNA processing can extend to this step by limiting Argonaute availability or by promoting degradation of mature miRNAs, thereby reducing the pool of functional miRNAs. Although GO:1903799 primarily focuses on processing, the boundary between processing and stability is functionally linked, and many studies consider both when assessing negative regulation of miRNA-mediated gene silencing. This integration ensures that cells can tightly control miRNA activity at multiple levels.
Key Genes Involved in GO:1903799 negative regulation of miRNA processing
The following genes and proteins are central to negative regulation of miRNA processing, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DROSHA | Catalytic subunit of the microprocessor complex that cleaves pri-miRNAs | Target for studying inhibition of pri-miRNA processing |
| DGCR8 | RNA-binding partner of Drosha that recognizes pri-miRNA hairpins | Knockout models reveal effects on miRNA maturation |
| DICER1 | Cleaves pre-miRNAs into mature miRNA duplexes in the cytoplasm | Mutations linked to altered miRNA processing in disease |
| TARBP2 | Dicer partner that facilitates pre-miRNA cleavage | Modulates Dicer activity and miRNA output |
| AGO2 | Loads mature miRNAs into RISC for gene silencing | Determines functional miRNA availability |
| LIN28A | Binds pri-miRNAs and pre-miRNAs to block processing | Model for negative regulation of let-7 processing |
| LIN28B | Blocks let-7 maturation and promotes stemness | Implicated in cancer and development |
| XPO5 | Exports pre-miRNAs from nucleus to cytoplasm | Altered export affects miRNA processing rates |
| SMAD proteins | Transduce TGF-beta signals that modulate miRNA processing | Link signaling pathways to miRNA maturation |
| p53 | Regulates transcription of miRNA host genes and microprocessor components | Connects stress responses to miRNA processing |
| MYC | Oncogenic transcription factor that represses certain miRNA genes | Drives miRNA downregulation in leukemia |
| EZH2 | Histone methyltransferase that silences miRNA genes epigenetically | Target for epigenetic regulation of miRNA processing |
| DNMTs | DNA methyltransferases that methylate miRNA promoters | Mediate transcriptional repression of miRNA genes |
| HDACs | Histone deacetylases that repress miRNA gene transcription | Modulate chromatin state at miRNA loci |
| KSRP | RNA-binding protein that can promote or inhibit miRNA processing | Context-dependent regulator of miRNA maturation |
| hnRNPA1 | Binds pri-miRNAs and can inhibit Drosha cleavage | Modulates processing of specific miRNA subsets |
| NF90/NF45 | RNA-binding complex that regulates pri-miRNA stability | Affects miRNA processing efficiency |
How Is negative regulation of miRNA processing Regulated?
Negative regulation of miRNA processing is itself regulated by multiple signaling pathways and cellular states. For example, TGF-beta signaling through SMAD proteins can modulate the expression or activity of microprocessor components, thereby altering miRNA maturation rates. Oncogenic transcription factors such as MYC can repress miRNA gene transcription, reducing pri-miRNA availability. Epigenetic modifiers including EZH2, DNMTs, and HDACs establish repressive chromatin states at miRNA loci, contributing to long-term downregulation of miRNA processing. Additionally, stress-responsive pathways can induce RNA-binding proteins that block Drosha or Dicer activity, providing rapid and reversible inhibition of miRNA maturation. These regulatory inputs ensure that miRNA output is coordinated with developmental, metabolic, and environmental cues.
negative regulation of miRNA processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Acute leukemia; represses miRNA genes | Knockout or overexpression in leukemia cell lines |
| EZH2 | Acute leukemia; epigenetic silencing of miRNAs | Point mutation or knockout in hematopoietic cells |
| DICER1 | Heart disease; altered miRNA processing | Cardiomyocyte-specific knockout |
| LIN28A | Cancer and stemness; blocks let-7 processing | Overexpression in cancer cell lines |
| DGCR8 | Neuropsychiatric disorders; miRNA processing defects | Conditional knockout in mouse brain |
Negative regulation of miRNA processing in acute leukemia
In acute leukemia, epigenetic silencing of miRNA genes through promoter methylation and histone modifications leads to reduced mature miRNA levels, which contributes to leukemogenesis. Oncogenic transcription factors such as MYC and epigenetic modifiers like EZH2 cooperate to repress miRNA expression, effectively enhancing negative regulation of miRNA processing. These findings highlight the importance of this process in hematological malignancies and suggest that restoring miRNA processing could have therapeutic potential.
Negative regulation of miRNA processing in osteosarcoma
Osteosarcoma is characterized by complex genomic alterations and dysregulated miRNA networks. Altered miRNA processing, including reduced expression of specific tumor-suppressive miRNAs, is associated with tumor progression and poor clinical outcomes. Negative regulation of miRNA processing may therefore contribute to the aggressive phenotype of osteosarcoma by lowering the abundance of miRNAs that normally restrain oncogenic pathways.
Negative regulation of miRNA processing in heart disease
Dysregulated miRNA processing has been implicated in cardiac hypertrophy, fibrosis, and heart failure. Changes in the expression or activity of Drosha, Dicer, and other microprocessor components can alter the mature miRNA landscape in the heart, contributing to pathological remodeling. Understanding negative regulation of miRNA processing in cardiac cells may reveal new targets for therapeutic intervention in heart disease.
Negative regulation of miRNA processing in neuropsychiatric disorders
miRNAs in the hypothalamus and other brain regions regulate social and anxiety-related behaviors. Negative regulation of miRNA processing can alter the availability of specific miRNAs that modulate neuronal gene expression, potentially contributing to neuropsychiatric phenotypes. Studying this process in animal models provides insight into how miRNA processing defects influence behavior and brain function.
From negative regulation of miRNA processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce mature miRNA levels? | CRISPR knockout cell line followed by small RNA-seq |
| Does a specific mutation in DICER1 alter pre-miRNA cleavage? | Point mutation knock-in in cancer cell lines |
| Does overexpression of LIN28A block let-7 processing? | Overexpression cell model with miRNA reporter assays |
| Where does a negative regulator localize relative to Drosha? | Tagged knock-in with immunofluorescence imaging |
| Which miRNAs are affected by epigenetic silencing? | Knockout of DNMTs or HDACs followed by miRNA profiling |
| Can restoring miRNA processing reverse a disease phenotype? | Knock-in of wild-type processing factor in disease models |
How to Study the negative regulation of miRNA processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Small RNA-seq | Mature miRNA abundance | Profiling miRNA changes after knockout or overexpression |
| Total RNA-seq | pri-miRNA and pre-miRNA levels | Detecting processing intermediates |
| In vitro cleavage assay | Drosha or Dicer enzymatic activity | Testing direct inhibition of processing |
| Luciferase reporter assay | Functional miRNA-mediated silencing | Validating target gene derepression |
| CRISPR screen | Identification of negative regulators | High-throughput discovery of processing inhibitors |
| Immunoprecipitation | Protein-protein and protein-RNA interactions | Mapping microprocessor complex components |
| Immunofluorescence | Subcellular localization of processing factors | Assessing nuclear vs cytoplasmic distribution |
| Western blot | Protein expression of Drosha, Dicer, AGO2 | Confirming knockout or overexpression efficiency |
Small RNA sequencing and miRNA profiling
Small RNA-seq is the primary method to quantify mature miRNA levels and assess the impact of negative regulation of miRNA processing. By comparing wild-type and mutant cells, researchers can identify specific miRNAs whose processing is affected. This approach also detects changes in pre-miRNA and pri-miRNA intermediates when combined with total RNA-seq.
CRISPR-based genetic screens
CRISPR knockout and activation screens can systematically identify genes that negatively regulate miRNA processing. Libraries targeting RNA-binding proteins, transcription factors, and epigenetic modifiers can reveal novel regulators. These screens require careful design of negative controls to avoid false positives in miRNA-mRNA interaction classification.
Biochemical assays for Drosha and Dicer activity
In vitro cleavage assays using recombinant Drosha/DGCR8 or Dicer/TRBP and radiolabeled pri-miRNA or pre-miRNA substrates measure direct effects on processing activity. These assays can test whether a candidate protein or mutation inhibits cleavage. They are often complemented by immunoprecipitation to assess complex formation.
miRNA target reporter assays
Luciferase reporters containing miRNA binding sites in the 3' UTR of a target gene measure functional miRNA activity. When combined with negative regulators of miRNA processing, these assays determine whether reduced processing leads to decreased silencing of target genes. This provides a functional readout of GO:1903799.
How CRISPR Can Be Used to Study GO:1903799 negative regulation of miRNA processing
Knockout
CRISPR knockout of candidate negative regulators of miRNA processing, such as LIN28A or EZH2, allows researchers to determine whether loss of the regulator increases mature miRNA levels. Knockout cell lines can be subjected to small RNA-seq to quantify changes in miRNA abundance and to identify specific miRNA families affected. This approach provides causal evidence for the role of a gene in GO:1903799.
Point Mutation
Point mutation knock-in can be used to dissect catalytic residues or regulatory phosphorylation sites in Drosha, Dicer, or DGCR8. By introducing specific mutations, researchers can test whether a particular amino acid is required for negative regulation of miRNA processing. These models are valuable for separating enzymatic activity from scaffolding functions.
Knock-in
Knock-in of tagged versions of processing factors, such as GFP-DGCR8 or HA-Dicer, enables visualization and immunoprecipitation of endogenous complexes. Tagged knock-in models help map the interactome of negative regulators and determine their subcellular localization. They also allow for precise measurement of protein levels without overexpression artifacts.
Overexpression
Overexpression of candidate negative regulators, such as LIN28A or hnRNPA1, can phenocopy inhibition of miRNA processing and reveal downstream effects on gene expression. Overexpression models are useful for testing whether a gene is sufficient to reduce mature miRNA levels. They are often combined with reporter assays to measure functional consequences.
How EDITGENE Supports negative regulation of miRNA processing Research
Researchers studying negative regulation of miRNA processing-related genes often need to determine whether a candidate gene is causally involved in reducing mature miRNA levels or whether its effect is secondary to broader changes in transcription or RNA stability. CRISPR-based models provide the gold standard for establishing causality by introducing precise genetic alterations in disease-relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of miRNA processing research.
Frequently Asked Questions About negative regulation of miRNA processing
What is negative regulation of miRNA processing (GO:1903799)?
It is any process that stops, prevents or reduces the frequency, rate or extent of microRNA processing, thereby lowering mature miRNA levels.
What genes are involved in negative regulation of miRNA processing?
Key genes include DROSHA, DGCR8, DICER1, TARBP2, AGO2, LIN28A, LIN28B, EZH2, DNMTs, HDACs, and MYC, among others.
How does negative regulation of miRNA processing affect cancer?
It can reduce tumor-suppressive miRNAs, contributing to leukemogenesis and osteosarcoma progression.
What diseases are linked to GO:1903799?
Acute leukemia, osteosarcoma, heart disease, and neuropsychiatric disorders have been associated with altered negative regulation of miRNA processing.
What methods are used to study negative regulation of miRNA processing?
Small RNA-seq, total RNA-seq, in vitro cleavage assays, luciferase reporters, CRISPR screens, and immunoprecipitation are commonly used.
How can CRISPR help study negative regulation of miRNA processing?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators in disease-relevant cells.
Which proteins block Drosha-mediated pri-miRNA cleavage?
RNA-binding proteins such as hnRNPA1, KSRP, and LIN28A can bind pri-miRNAs and inhibit Drosha cleavage.
Does Dicer activity get negatively regulated?
Yes, Dicer can be inhibited by RNA-binding proteins or viral factors, reducing pre-miRNA cleavage and mature miRNA production.
What is the role of epigenetic silencing in miRNA processing?
Promoter methylation and histone modifications can repress miRNA gene transcription, reducing pri-miRNA availability and mature miRNA levels.
Why is negative regulation of miRNA processing important for gene expression?
It controls the abundance of mature miRNAs, which in turn regulate hundreds of target mRNAs, affecting broad gene expression programs.
Conclusion
Negative regulation of miRNA processing (GO:1903799) is a critical layer of gene expression control that determines the abundance of mature miRNAs and their downstream effects on target mRNAs. Dysregulation of this process is implicated in acute leukemia, osteosarcoma, heart disease, and neuropsychiatric disorders, making it a compelling area for both basic and translational research. Advances in CRISPR-based models and small RNA sequencing now enable precise dissection of the genes and mechanisms that negatively regulate miRNA processing, offering new opportunities for therapeutic intervention.
References
- 1. Narayanan R et al.. 2020. miRNA regulation of social and anxiety-related behaviour.. Cell Mol Life Sci 77(21):4347-4364 PMID: 32409861
- 2. Zhang J et al.. 2015. MicroRNAs in osteosarcoma.. Clin Chim Acta 444:9-17 PMID: 25661090
- 3. Towler BP et al.. 2015. Mechanisms of regulation of mature miRNAs.. Biochem Soc Trans 43(6):1208-14 PMID: 26614662
- 4. Cohen-Davidi E et al.. 2024. Benchmarking the negatives: Effect of negative data generation on the classification of miRNA-mRNA interactions.. PLoS Comput Biol 20(8):e1012385 PMID: 39186797
- 5. Cordeiro MA et al.. 2025. MicroRNAs' Impact on Heart Diseases.. Int J Mol Sci 26(12) PMID: 40565029
- 6. Agirre X et al.. 2012. Epigenetic regulation of miRNA genes in acute leukemia.. Leukemia 26(3):395-403 PMID: 22143672
- 7. Meister B et al.. 2013. MicroRNAs in the hypothalamus.. Neuroendocrinology 98(4):243-53 PMID: 24080764
- 8. Seida M et al.. 2025. Fine Regulation of MicroRNAs in Gene Regulatory Networks and Pathophysiology.. Int J Mol Sci 26(7) PMID: 40243428
